Application
Antibodies tested include p-PKC βI (Thr 642): (A, B, C) and PKC βI (E-3): (D, E, F).
Application
Western blot analysis of PKC βI phosphorylation in untreated (A), nocodazole treated (B) and lambda protein phosphatase (A) and nocodazole treated (C) K-562 whole cell lysates.
Application
Western blot analysis of phosphorylated PKC βI expression in untreated (A) and PMA-treated (B) K-562 whole cell lysates.
Application
Immunoperoxidase staining of formalin-fixed, paraffin-embedded human lung carcinoma tissue showing cytoplasmic staining.